OpenVSafe by OpenVAERS
Search V-safe

YLD-13947-72852

5 vaccinations 9 coded responses 48 check-ins 8 free-text entries 1 call case
Sex
Female
Age at first dose
46-50
ZIP prefix
774 / TX
Registered
2020-12-23
Relationship
Self
Race
White
Ethnicity
Hispanic or Latino
Registered dependents
9TG-33345-73663 Child or adolescent in my care · Female · 2021-11-14
M45-23148-45433 Child or adolescent in my care · Male · 2021-11-14

Possible VAERS report

VAERS IDConfidenceScoreRunner-upShared symptomsDose StateVAERS vaccinated / onset / receivedCall case
2567867 (opens in a new window) high 9 / 11 -1 1 of 12 VAERS symptoms same dose (5) TX matches 2022-10-21 / 2022-12-24 / 2023-01-25
received the same day as the last call
 case 85026

From the VAERS matching of call center cases (loader/vaers_match_*). Only the best match is shown, and only if it scores 8 or more out of 11. The score adds up timing (VAERS received soon after the call center contact), dose and shared symptoms; state only breaks ties. Confidence is high when the score is 8+ and at least 3 points ahead of the runner-up, medium when 5+ and 2 ahead, otherwise low. A match is a likely link, not a confirmed one.

Timeline

  1. 2020-12-23
    Registered in v-safe
  2. 2020-12-23
    Dose 1 — Pfizer-BioNTech
  3. 2020-12-23
    Health check-in — day 0, dose 1
    Feeling: Good · None
    Adult check-in
  4. 2020-12-24
    Survey response — days 1–6 daily, dose 1
    MedDRA: Erythema, Induration, Skin discolouration, Swelling, Tenderness — Feeling: Good · Site: Pain, Redness, Swelling
    Free text: Pain is when area is touched. Redness is the size of a quarter and more pinkish. Swelling is very mild with enduration.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  5. 2020-12-25
    Survey response — days 1–6 daily, dose 1
    MedDRA: Erythema, Induration — Feeling: Good · Site: Redness · Joint pains
    Free text: Redness is less and same size as yesterday, quarter size with enduration a little less than yesterday.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  6. 2020-12-26
    Survey response — days 1–6 daily, dose 1
    MedDRA: Arthralgia, Injection site erythema, Injection site induration — Feeling: Good · Site: Redness
    Free text: Redness at the injection site is almost gone, enduration is less and no pain when touching. Joint pain is gone.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  7. 2020-12-27
    Survey response — days 1–6 daily, dose 1
    MedDRA: Injection site erythema, Injection site induration, Injection site swelling — Feeling: Good · Site: Swelling
    Free text: Swelling very mild with enduration at injection site. Redness resolved. No pain on touch.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  8. 2020-12-28
    Survey response — days 1–6 daily, dose 1
    MedDRA: Injection site pain — Feeling: Good · Site: Swelling
    Free text: Just a little soreness at the enduration/injection site.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  9. 2020-12-29
    Survey response — days 1–6 daily, dose 1
    MedDRA: Injection site induration — Feeling: Good
    Free text: Enduration at injection site resolved.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  10. 2020-12-30
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  11. 2021-01-06
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  12. 2021-01-13
    Dose 2 — Pfizer-BioNTech
  13. 2021-01-13
    Health check-in — day 0, dose 2
    Feeling: Good · None
    Adult check-in
  14. 2021-01-14
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain · None
    Adult check-in
  15. 2021-01-15
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  16. 2021-01-16
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  17. 2021-01-17
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  18. 2021-01-18
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  19. 2021-01-19
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  20. 2021-01-22
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  21. 2021-01-27
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  22. 2021-02-03
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  23. 2021-02-10
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  24. 2021-02-17
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  25. 2021-02-24
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  26. 2021-04-14
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  27. 2021-07-15
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  28. 2021-10-01
    Dose 3 — Pfizer-BioNTech
  29. 2021-10-02
    Health check-in — days 1–6 daily, dose 3
    Feeling: Fair · Site: Pain, Itching · Fever · Headache, Joint pains, Muscle or body aches
    Adult check-in
  30. 2021-10-03
    Health check-in — days 1–6 daily, dose 3
    Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness
    Adult check-in
  31. 2021-10-04
    Survey response — days 1–6 daily, dose 3
    MedDRA: Mobility decreased, Pain — Feeling: Good · Site: Pain · Joint pains, Muscle or body aches
    Free text: Last night was very painful that I did not even want to move, today much better almost gone
    MedDRA releases: 2024-11 · check-in free text available
  32. 2021-10-05
    Survey response — days 1–6 daily, dose 3
    MedDRA: Adverse reaction — Feeling: Good · Joint pains, Muscle or body aches
    Free text: Very mild
    MedDRA releases: 2024-11 · check-in free text available
  33. 2021-10-06
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  34. 2021-10-07
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  35. 2021-10-08
    Health check-in — day 7, dose 3
    Feeling: Good · None
    Adult check-in
  36. 2021-10-17
    Health check-in — day 14, dose 3
    Feeling: Good
    Adult check-in
  37. 2021-10-22
    Health check-in — day 21, dose 3
    Feeling: Good
    Adult check-in
  38. 2021-10-29
    Health check-in — day 28, dose 3
    Feeling: Good
    Adult check-in
  39. 2021-11-05
    Health check-in — day 35, dose 3
    Feeling: Good
    Adult check-in
  40. 2021-11-12
    Health check-in — day 42, dose 3
    Feeling: Good
    Adult check-in
  41. 2021-12-31
    Health check-in — 3 months, dose 3
    Feeling: Good
    Adult check-in
  42. 2022-04-01
    Health check-in — 6 months, dose 3
    Feeling: Good
    Adult check-in
  43. 2022-07-01
    Dose 4 — Pfizer-BioNTech
  44. 2022-10-01
    Health check-in — 12 months, dose 3
    Feeling: Good
    Adult check-in
  45. 2022-10-21
    Dose 5 — Pfizer-BioNTech
  46. 2022-10-26
    Health check-in — days 1–6 daily, dose 5
    Feeling: Good · Joint pains
    Adult check-in
  47. 2022-10-27
    Health check-in — days 1–6 daily, dose 5
    Feeling: Good · Joint pains
    Adult check-in
  48. 2022-10-30
    Health check-in — day 7, dose 5
    Feeling: Good · None
    Adult check-in
  49. 2022-11-04
    Health check-in — day 14, dose 5
    Feeling: Good
    Adult check-in
  50. 2022-11-11
    Health check-in — day 21, dose 5
    Feeling: Good
    Adult check-in
  51. 2022-11-18
    Health check-in — day 28, dose 5
    Feeling: Good
    Adult check-in
  52. 2022-12-02
    Health check-in — day 42, dose 5
    Feeling: Good
    Adult check-in
  53. 2023-01-20
    Survey response — 3 months, dose 5
    MedDRA: Bell's palsy — Feeling: Good · Get care from a doctor or other healthcare professional · Emergency room or emergency department visit, Hospitalization
    MedDRA releases: 2024-11
  54. 2023-01-20
    Report sent to call center — 3 months, dose 5
    Get care from a doctor or other healthcare professional
    Emergency room or emergency department visit · Hospitalization · 1 call case(s)
  55. 2023-01-23
  56. 2023-01-24
  57. 2023-01-25
    Call successful
    Completed over the phone
  58. 2023-04-21
    Health check-in — 6 months, dose 5
    Feeling: Good
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12020-12-23Pfizer-BioNTech
22021-01-13Pfizer-BioNTech
32021-10-01Pfizer-BioNTech No
42022-07-01Pfizer-BioNTech No
52022-10-21Pfizer-BioNTech No

Call center

ReportedOutcomeVAERS-related outcome
2023-01-20 Successful
2023-01-25
 Completed over the phone

Free text

Release 1 — days 1–6 daily, dose 1

2020-12-24

Systemic reaction (other): Pain is when area is touched. Redness is the size of a quarter and more pinkish. Swelling is very mild with enduration.

2020-12-25

Systemic reaction (other): Redness is less and same size as yesterday, quarter size with enduration a little less than yesterday.

2020-12-26

Systemic reaction (other): Redness at the injection site is almost gone, enduration is less and no pain when touching. Joint pain is gone.

2020-12-27

Systemic reaction (other): Swelling very mild with enduration at injection site. Redness resolved. No pain on touch.

2020-12-28

Systemic reaction (other): Just a little soreness at the enduration/injection site.

2020-12-29

Systemic reaction (other): Enduration at injection site resolved.

Release 9 — days 1–6 daily, dose 3

2021-10-04

Systemic reaction (other): Last night was very painful that I did not even want to move, today much better almost gone

Release 10 — days 1–6 daily, dose 3

2021-10-05

Systemic reaction (other): Very mild

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDBell's palsy · · ✓
SROAdverse reaction · · ✓
SROArthralgia ✓ ✓ ✓
SROErythema ✓ ✓ ✓
SROInduration ✓ ✓ ✓
SROInjection site erythema ✓ ✓ ✓
SROInjection site induration ✓ ✓ ✓
SROInjection site pain ✓ ✓ ✓
SROInjection site swelling ✓ ✓ ✓
SROMobility decreased · · ✓
SROPain · · ✓
SROSkin discolouration ✓ ✓ ✓
SROSwelling ✓ ✓ ✓
SROTenderness ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release

Loading…